Companies
Teknova
launched Build-Tek, a proprietary AI reagent assistant that lets customers configure complex custom buffer and reagent requests in minutes, alongside its AAV-Tek product line for gene-therapy manufacturing buffers; confirmed via multiple press releases and industry coverage of the Build-Tek launch.
- Country
- United States
- Ticker
- AKYA
Custom buffer configuration
Coverage
| US | |
|---|---|
| consumables | ✓ |
Regulatorsfda
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Raised 2026 revenue guidance to $45-47 million | last10k.com · pulse2.com · biospace.com |
| Capacity | Flexible batch sizes from 8 liters up to 2,000 liters | ir.teknova.com · globenewswire.com · stocktitan.net · teknova.com |
| Certification | ISO 13485:2016 certified quality management system | ir.teknova.com · globenewswire.com · stocktitan.net · teknova.com |
| Production site | Hollister, California | pharmaceutical-technology.com · teknova.com |
| Revenue | $12.2 million for the second quarter of 2026 | last10k.com · pulse2.com · biospace.com |
Independent sources: biospace.com · globenewswire.com · last10k.com · pharmaceutical-technology.com · pulse2.com · stocktitan.net
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Ready-made buffer solutions | consumables | High | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.